Dallas-based Genomics Startup Secures Private Equity Investment
To suggest that local, Dallas AI-Genomics company Phronetik, has stayed busy in 2024 would be an understatement. Phronetik CEO, Dr. Tania Martin-Mercado, has been actively structuring leadership within the company as it prepares for an injection of private capital. Founded in 2013, Phronetik integrates genomics into research and patient care using OMICS data, AI, bioinformatics, and health IT support to enhance diagnosis, treatment, and patient care. The company collaborates with universities and labs, focusing on precision medicine and inclusive research. 
Dallas-based Genomics Startup Secures Private Equity Investment